Skip to Content Skip to Content

Internal Medicine

Researchers discover test to predict which patients with rare blood disease will respond to only FDA-approved treatment, and identify alternative therapy

Researchers discover test to predict which patients with rare blood disease will respond to only FDA-approved treatment, and identify alternative therapy

David Fajgenbaum and Sheila Pierson of the Perelman School of Medicine discuss their latest research and findings in the treatment of Castleman disease.

The best new implants may be a piece of you
Stacy Haley standing near a vase of flowers holding out an arm.

HUP patient Stacy Haley received free-flap reconstruction surgery after receiving a double mastectomy. (Image: Penn Medicine News)

The best new implants may be a piece of you

Innovative techniques like autologous surgery involves implanting patients with something taken from a different part of their body, which eliminates the risk of infection and erosion of synthetic materials.

From Penn Medicine News

Tower Health’s liver and kidney transplant program will move to Penn Medicine

Tower Health’s liver and kidney transplant program will move to Penn Medicine

Tower Health announced Wednesday that instead of closing the liver and kidney transplant program it inherited two years ago from the shuttered Hahnemann University Hospital outright, it will let Penn Medicine take it over. Patient screening and pre- and post-transplant care will continue at Reading Hospital in Berks County, but surgeries will move to Penn’s Hospital of the University of Pennsylvania in Philadelphia in mid-December.

Cytokine treatment promotes weight loss by ‘sweating’ fat
Cross section of a hair follicle surrounded by cells.

Penn Medicine researchers discovered that obese mice were able to shed 40% of their body weight by secreting fat through their skin. (Image: Penn Medicine News)

Cytokine treatment promotes weight loss by ‘sweating’ fat

A seemingly unremarkable observation—greasy hair—showed Penn researchers how the immune system could be targeted to reverse obesity.

Lauren Ingeno

Getting to the heart of genetic cardiovascular diseases
Sharlene M. Day looking in a microscope in a lab wearing a lab coat and latex gloves.

Sharlene M. Day, presidential associate professor of cardiovascular medicine and director of Translational Research for the Penn Cardiovascular Institute. (Image: Penn Medicine News)

Getting to the heart of genetic cardiovascular diseases

Day, a physician-scientist and cardiologist works to unlock the mysteries of genetic heart disease, integrating translational and clinical science to understand the full spectrum of genetic heart disease evolution and progression.

From Penn Medicine News

Lipids model how to explore for unexpected diseases
Lipid panel with check marks with a stethoscope resting on top of the file.

Lipids model how to explore for unexpected diseases

Lipids are known heritable risk factors for cardiovascular disease, but increasing evidence also supports shared genetics with diseases of other organ systems.

From Penn Medicine News

Med study illuminates the molecular details of lung development
Diagram of lungs comprised of microscopic dots.

Med study illuminates the molecular details of lung development

Researchers at Penn Medicine have produced a detailed molecular atlas of lung development, key for future studies of mammalian biology and of new treatments for diseases, such as COVID-19, that affect the lungs.

Melissa Moody

Racial and ethnic factors affect access to treatment for heart disease
Hand holding a blood pressure gauge measuring the blood pressure of another person whose arm is extended.

Racial and ethnic factors affect access to treatment for heart disease

Researchers uncover a link between racial, ethnic, and socioeconomic factors and whether Black, Latinx, and lower-income patients receive rhythm control strategies for atrial fibrillation.

From Penn Medicine News